Rob Hershberg

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 29% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Director Fate Therapeutics Inc May 1, 2020 -
Independent Director Adaptive Biotechnologies Corporation Feb. 1, 2013 -
Independent Director NanoString Technologies Inc March 2, 2015 -
Chief Scientific Officer Celgene Corp Jan. 8, 2016 - April 28, 2016

Rob Hershberg's trades of Recursion Pharmaceuticals Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
37.74
Quantity 49,302 +21.8%
Value US$2,984,269
Transaction date
Proposed sale
Price
28.47
Quantity 31,350
Value US$1,566,557
Transaction date
Planned sale
Price
4.96
Quantity 100,000 -50.0%
Value US$496,000
Transaction date
Proposed sale
Price
4.96
Quantity 100,000
Value US$496,000
Transaction date
Sale
Price
1.76
Quantity 11,901 -1.1%
Value US$21,003
Transaction date
Sale
Price
1.89
Quantity 14,634 -1.3%
Value US$27,658
Transaction date
Sale
Price
14.93
Quantity 11,597 -1.2%
Value US$173,161
Transaction date
Proposed sale
Price
14.00
Quantity 72,000
Value US$1,008,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-07 2026-10-06 S Sale
49,302 +21.8%
37.74
US$2,984,269
49,302 +21.8% 37.74 US$2,984,269
2026-10-06 2026-10-06 PrS Proposed sale
31,350
28.47
US$1,566,557
31,350 28.47 US$1,566,557
2026-08-20 2026-08-18 S Sale
41,798 -7.1%
255.39
US$4,034,300
41,798 -7.1% 255.39 US$4,034,300
2026-08-20 2026-08-18 S Sale
15,000 -19.4%
24.39
US$365,850
15,000 -19.4% 24.39 US$365,850
2026-08-18 2026-08-18 PrS Proposed sale
30,664
24.40
US$748,303
30,664 24.40 US$748,303
2026-07-09 2026-07-07 PlS Planned sale
100,000 -50.0%
4.96
US$496,000
100,000 -50.0% 4.96 US$496,000
2026-07-07 2026-07-07 PrS Proposed sale
100,000
4.96
US$496,000
100,000 4.96 US$496,000
2025-12-12 2025-12-10 S Sale
22,968 -33.0%
16.00
US$367,488
22,968 -33.0% 16.00 US$367,488
2025-12-10 2025-12-10 PrS Proposed sale
22,968
16.00
US$367,488
22,968 16.00 US$367,488
2025-03-12 2025-03-12 PrS Proposed sale
53,000
7.59
US$402,270
53,000 7.59 US$402,270
2025-03-12 2025-03-12 S Sale
53,000 -43.2%
7.59
US$402,270
53,000 -43.2% 7.59 US$402,270
2025-02-12 2025-02-11 S Sale
11,901 -1.1%
1.76
US$21,003
11,901 -1.1% 1.76 US$21,003
2025-02-12 2025-02-04 S Sale
14,634 -1.3%
1.89
US$27,658
14,634 -1.3% 1.89 US$27,658
2024-02-12 2024-02-08 S Sale
11,597 -1.2%
14.93
US$173,161
11,597 -1.2% 14.93 US$173,161
2024-01-22 2024-01-22 PrS Proposed sale
72,000
14.00
US$1,008,000
72,000 14.00 US$1,008,000
2022-06-06 2022-06-03 S Sale
672 -25.1%
22.75
US$15,288
672 -25.1% 22.75 US$15,288
2021-04-19 2021-04-15 PlS Planned sale
118 -5.9%
74.20
US$8,756
118 -5.9% 74.20 US$8,756
2021-04-19 2021-04-15 PlS Planned sale
19 -0.9%
72.87
US$1,385
19 -0.9% 72.87 US$1,385
2021-04-19 2021-04-15 PlS Planned sale
7 -0.3%
71.75
US$502
7 -0.3% 71.75 US$502
2021-03-17 2021-03-15 PlS Planned sale
1,214 -39.1%
67.16
US$81,532
1,214 -39.1% 67.16 US$81,532
2021-03-17 2021-03-15 PlS Planned sale
282 -8.3%
66.03
US$18,620
282 -8.3% 66.03 US$18,620
2021-03-17 2021-03-15 PlS Planned sale
4 -0.1%
63.58
US$254
4 -0.1% 63.58 US$254
2021-03-10 2021-03-08 PlS Planned sale
2,000 -57.1%
44.56
US$89,120
2,000 -57.1% 44.56 US$89,120
2021-03-10 2021-03-08 PlS Planned sale
2,000 -100.0%
44.56
US$89,120
2,000 -100.0% 44.56 US$89,120
2021-02-18 2021-02-16 PlS Planned sale
69 -3.5%
83.93
US$5,791
69 -3.5% 83.93 US$5,791
2021-02-18 2021-02-16 PlS Planned sale
163 -7.7%
82.83
US$13,501
163 -7.7% 82.83 US$13,501
2021-02-18 2021-02-16 PlS Planned sale
156 -6.8%
81.79
US$12,759
156 -6.8% 81.79 US$12,759
2021-02-18 2021-02-16 PlS Planned sale
159 -6.5%
80.55
US$12,807
159 -6.5% 80.55 US$12,807
2021-02-18 2021-02-16 PlS Planned sale
323 -11.7%
79.53
US$25,688
323 -11.7% 79.53 US$25,688
2021-02-18 2021-02-16 PlS Planned sale
318 -10.3%
78.40
US$24,931
318 -10.3% 78.40 US$24,931
2021-02-17 2021-02-16 PlS Planned sale
2,000 -57.1%
65.45
US$130,900
2,000 -57.1% 65.45 US$130,900
2021-01-20 2021-01-15 PlS Planned sale
622 -100.0%
67.05
US$41,705
622 -100.0% 67.05 US$41,705
2021-01-20 2021-01-15 PlS Planned sale
1,378 -68.9%
66.34
US$91,417
1,378 -68.9% 66.34 US$91,417
2021-01-19 2021-01-15 PlS Planned sale
90 -4.5%
74.55
US$6,710
90 -4.5% 74.55 US$6,710
2021-01-19 2021-01-15 PlS Planned sale
291 -12.8%
73.66
US$21,435
291 -12.8% 73.66 US$21,435
2021-01-19 2021-01-15 PlS Planned sale
410 -15.3%
72.91
US$29,893
410 -15.3% 72.91 US$29,893
2021-01-19 2021-01-15 PlS Planned sale
709 -20.9%
71.77
US$50,885
709 -20.9% 71.77 US$50,885
2020-12-16 2020-12-15 PlS Planned sale
241 -100.0%
57.01
US$13,739
241 -100.0% 57.01 US$13,739
2020-12-16 2020-12-15 PlS Planned sale
1,759 -87.9%
55.78
US$98,117
1,759 -87.9% 55.78 US$98,117
2020-12-16 2020-12-15 PlS Planned sale
812 -30.1%
69.88
US$56,743
812 -30.1% 69.88 US$56,743
2020-12-16 2020-12-15 PlS Planned sale
688 -20.3%
68.68
US$47,252
688 -20.3% 68.68 US$47,252
2020-11-18 2020-11-16 PlS Planned sale
746 -28.3%
47.03
US$35,084
746 -28.3% 47.03 US$35,084
2020-11-18 2020-11-16 PlS Planned sale
754 -22.2%
46.31
US$34,918
754 -22.2% 46.31 US$34,918
2020-11-18 2020-11-16 PlS Planned sale
223 -100.0%
48.41
US$10,795
223 -100.0% 48.41 US$10,795
2020-11-18 2020-11-16 PlS Planned sale
1,777 -88.8%
47.60
US$84,585
1,777 -88.8% 47.60 US$84,585

See older Rob Hershberg insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Rob Hershberg history with Plus

Billed monthly · Cancel anytime